ArticleJournal of animal science2025
Dosing and fecal sample collection effects on the estimates of intake using n-alkanes as markers.
Article in Journal of animal science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Forage intake and digesta kinetics of lactating beef cattle differing in feed efficiency while grazing Idaho rangelands.Journal of animal science · 2026Article
- Dosing frequency, fecal sampling, and digestibility method influence titanium dioxide-based intake estimates in dairy heifers.Journal of animal science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of indigestible markers continues to be among the best tools available for estimating dry matter intake (DMI) in situations where individual animal feeding cannot be feasibly measured. The constant animal handling required for dosing markers and subsequent fecal sample collection required are often limiting, especially when grazing or when animal handling facilities are not accessible. Identifying strategies for more efficient use of labor while not sacrificing the accuracy of DMI estimates are important for further application of these techniques. The objectives of this study were to: 1) Test potential diet and dosing effects of C32 n-alkane for intake estimates; 2) Compare intake estimates from 2 contrasting (i.e., intensive vs. less intensive) fecal sampling regimes; and 3) Determine whether intake estimates differ when 2 different n-alkane pairs (C31:C32 or C32:C33) are used. The study was laid out using a 2 × 2 × 2 factorial arrangement in a randomized complete block design. Treatments were 2 diets, 2 n-alkane marker dosing regimens, and 2 fecal sampling regimens. Diets were grass haylage (HLG) and a total mixed ration (TMR). Daily intakes were recorded using Calan gates. Alkane dosing was once (1×) or twice (2×) daily dosing of a bolus containing dotriacontane (C32) n-alkane. The 1× treatments received 2 capsules every morning, while the 2× treatments received 1 capsule in the morning and 1 in the afternoon, both receiving 933 mg of C32/d. Fecal samples were either taken 3 times daily over 4 d with times shifted each day (4 × 3), or twice daily at the same times each day (AMPM). The results indicate the use of C32:C33 n-alkane pairs were not accurate for predicting DMI (Lin's Concordance Correlation Coefficient [CCC] all < 0.5). The C31:C32 n-alkane pairs provided accurate estimates of DMI, having adequate agreement (CCC >0.6) between predicted and observed DMI estimates. Strategies for dosing either 1× or 2× daily were both accurate, within the confines of the experiment. In terms of fecal sampling, there was no discernable advantage for the intensive (4 × 3) sampling regimen compared to the twice daily (AMPM) sampling. In addition, intake estimates were similar with either the 1× or 2× dosing regimens. For studies conducted under similar conditions, it may be suitable to adopt 1× dosing regimen with twice-daily fecal sampling schedules.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.